Notice ID: 8af7241dbb4242739699576e18ea20faSpecial Notice
66--Notice of Intent to Sole Source
Archived on October 31, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM EDT
- Posted
- October 6, 2026
- Notice type
- Special Notice
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
- Agency
- Environmental Protection Agency
Notice details
- Office
- WATER, TRIBAL & SCIENCE DIVISION
- Last updated
- Oct 31, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 68HERW27Q0002
- Notice ID
- 8af7241dbb4242739699576e18ea20fa
Description
PSC 6630
This is a sole source requirement to contract with Thermo Electron North America LLC To purchase hardware, a computer, and software
necessary to modify and upgrade our current THERMO Ion Chromatograph and connect it to our current High Resolution Mass Spectrometer. This
procurement includes both parts and installation.
This is a sole source requirement to contract with Thermo Electron North America LLC To purchase hardware, a computer, and software
necessary to modify and upgrade our current THERMO Ion Chromatograph and connect it to our current High Resolution Mass Spectrometer. This
procurement includes both parts and installation.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Links (1)
- Click here to see more information about this opportunity on FedConnectwww.fedconnect.netPosted
Lifecycle
- 1Version 1Special NoticeCurrent
66--Notice of Intent to Sole Source
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
MultiScan-AR from Los Alamos National Laboratory turns a routine mass spectrometry run into a high-resolution portrait of a microbe and its defenses, giving care teams the identity of a pathogen and its antibiotic-resistance profile in minutes to hours rather than the better part of a day. The method works with instruments that clinics and field laboratories already operate, from benchtop analyzers to portable units, so its advanced scanning technique and analysis pipeline add new diagnostic power without demanding an entirely new hardware footprint. For any organization racing to slow the spread of drug-resistant infections, the payoff is faster, more confident treatment decisions and a meaningful edge in patient care and public health. Overview The Multidimensional Mass Fingerprinting for Antibiotic-Resistant Bacteria approach begins by capturing bacteria or fungi from a sample onto a collection material, then breaking those cells open to release their internal parts. The released components are analyzed by mass spectrometry using matrix-assisted laser desorption ionization, a technique that gently and reproducibly converts molecules into measurable ions. Rather than take a single snapshot, MultiScan-AR applies a multidimensional scan that collects fragmentation data across the entire mass range and in both positive and negative charge modes, yielding far richer detail than a standard fingerprint. A dedicated data pipeline then organizes and annotates that complex output into a multidimensional mass fingerprint, allowing the system to identify the organism and flag the subtle molecular changes that signal antibiotic resistance. Technology Description MultiScan-AR is built around a multidimensional tandem mass spectrometry technique that interrogates lysed microbial samples with a level of granularity beyond conventional strain-typing instruments. Antibiotic resistance frequently arises from specific modifications to a cell's machinery, whether inside the cell through inactivating enzymes or at its surface through structures such as efflux pumps, and these differences are usually invisible to tools designed only to separate one species from another. By defining unique tandem fragmentation windows and stepping them across the full mass range, the method gathers MS and MS/MS information that captures those resistance-linked features rather than a coarse profile. The resulting data set is intentionally dense, combining precursor-mass and product ion-level measurements in both ionization modes, and a purpose-built processing pipeline renders it as a single multidimensional mass fingerprint for interpretation. Because the technique layers onto established platforms such as benchtop biotyping analyzers and portable field spectrometers, labs can reach species-level identification and resistance profiling on the order of minutes to hours instead of waiting on culture-dependent workflows. The practical result reinforces a more discriminating readout that distinguishes closely related strains, supports better-informed antibiotic choices and strengthens efforts to contain resistant organisms. Advantages • Delivers pathogen identification and antibiotic-resistance information in minutes to hours • Distinguishes even closely related bacterial strains that routine methods tend to miss • Works with mass spectrometry instruments already present in clinics and field settings, including portable units • Reduces reliance on prior knowledge of the suspected organism, unlike many antibody-based tests • Helps prevent incorrect antibiotic prescriptions and the resistance they encourage • Suits hospital, point-of-care and field-forward environments Market Applications • Clinical Diagnostics (hospital or core laboratories, infectious-disease testing) • Point-of-care Testing (urgent care, bedside diagnostics) • Public Health and Biosurveillance (outbreak monitoring, resistance tracking) • Field-deployable Medicine (military medicine, remote or austere care settings) • Analytical Instrument Platforms (mass spectrometry providers, diagnostic software) • Antimicrobial Research (drug development, resistance studies) TRL 3 U.S. Patent pending LA-UR-26-27335 LANL Tech Partnerships: Unlock the Innovative Potential Los Alamos National Laboratory offers a wide range of cutting-edge technologies and capabilities that may provide your company with a competitive edge in the market and unlock the innovative potential that can enhance, refine, and revolutionize your products. LANL’s licensing program focuses on moving inventions developed by our researchers to commercial innovations. Patented and patent pending inventions and copyrighted software are available to existing and start-up companies through exclusive and non-exclusive licensing agreements. For specific discussions, please contact licensing@lanl.gov. Note: This is not a call for external services for the development of this technology. https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology m.lanl.gov/tech-search | - | Special Notice | 10/01/2026 |
LiSA (Lithium Sensing with Advanced Polymer Systems) is a field-deployable, polymer-based sensing platform from Los Alamos National Laboratory that enables rapid, in situ detection of lithium in geothermal brines and clay-rich formations — eliminating the need for costly full-depth drilling and time-intensive laboratory assays during early-stage exploration. Engineered to operate under variable temperature, salinity and pH conditions typical of lithium-hosting environments, LiSA allows exploration teams to confirm lithium presence in real time, reduce exploration risk and accelerate resource validation. By lowering costs, shortening decision cycles and improving targeting accuracy, the technology addresses a critical bottleneck in domestic lithium development and offers scalable potential for adaptation to other critical minerals, positioning licensees at the forefront of next-generation resource exploration. Technology Description: LiSA works by using a specially designed sensing material that selectively recognizes lithium when it comes into contact with underground fluids or soil. The sensing material is integrated into a portable platform that can be deployed directly in the field, where it interacts with samples onsite and produces a measurable signal if lithium is present. Because the sensing component is engineered to remain stable under the high salinity, temperature and varying chemical conditions typical of lithium-bearing environments, it can function reliably outside of a laboratory setting. In essence, the system translates the chemical presence of lithium into a rapid, field-readable response that helps guide exploration decisions in real time. The Opportunity: By integrating LiSA’s selective sensing technology into exploration services, downhole tools, surface sampling systems, geothermal operations or direct lithium extraction (DLE) platforms, our partners can offer their customers faster resource validation, reduced exploration risk and improved decision-making in the field. LiSA provides a pathway to differentiate your portfolio with real-time, on-site lithium detection capability while positioning your organization at the forefront of domestic critical mineral development, with potential expansion into sensing for other high-value elements as market demand evolves. Key Advantages: Field-deployable and portable – Enables onsite lithium detection rather than requiring laboratory analysis. In situ measurement – Identifies lithium directly in subsurface fluids and soils without full core recovery. Faster decision-making – Provides near real-time results to guide drilling and exploration strategy. Lower exploration costs – Reduces reliance on expensive drilling campaigns and lab assays. Operates in harsh environments – Engineered to function under variable temperature, salinity, and pH typical of geothermal and clay systems. Platform adaptability – Tunable polymer approach offers potential extension to other critical minerals. Market Applications: Lithium mining and mineral exploration Geothermal energy development Direct lithium extraction and brine processing Oil and gas field services and subsurface technologies Analytical instrumentation and field sensing technologies Development Status: TRL 4 US Patent pending LA-UR-26-23292 LANL Tech Partnerships: Unlock the Innovative Potential Los Alamos National Laboratory offers a wide range of cutting-edge technologies and capabilities that may provide your company with a competitive edge in the market and unlock the innovative potential that can enhance, refine, and revolutionize your products. LANL’s licensing program focuses on moving inventions developed by our researchers to commercial innovations. Patented and patent pending inventions and copyrighted software are available to existing and start-up companies through exclusive and non-exclusive licensing agreements. For specific discussions, please contact licensing@lanl.gov. Note: This is not a call for external services for the development of this technology. https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology m.lanl.gov/tech-search | - | Special Notice | 12/07/2026 |
**THIS IS A SOLE SOURCE REQUIREMENT** Facility Modicon PLC Control hardware. Upgrading obsolete drops. | - | Special Notice | 11/13/2026 |
Indefinite Delivery Contract: Estimated quantity 77.000 ; Not to Exceed 350,000.00 | - | Awarded | Open |
Notice of Intent to Sole-Source Requirement The Department of Veterans Affairs, Network Contracting Office (NCO) 10, intends to negotiate a sole source contract under Simplified Acquisition Procedures and the authority of FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The associated NAICS code for this is 334516, Size Standard is 1,000 employees. Product Service Code (PSC) is Q301. The sole-source contract will be awarded to: VERACYTE, INC UEI: JS7GBP6LCMN6 Description of equipment requirements: The VA Northeast Ohio Healthcare System (VANEOHS) requires continued access to specialized genomic classifier testing used to assess risk of metastasis or metastatic progression in patients with localized or advanced prostate cancer. Decipher prostate testing is a powerful diagnostic and prognostic tool that assesses risk of prostate cancer progression within the next five years post detection, biopsy or surgical removal. The test utilizes a genome-wide transcriptome assay to analyze the expression of 22 genes to generate the Decipher score. Performed on existing tissue samples obtained during biopsy or surgical removal of the prostate, prior to any radiation or hormone therapy. Indicated in localized, N1, or metastatic disease. Provides the Decipher score based on genomic characteristics of the tumor, independent of clinical and pathological factors. The score, ranging between 0 and 1, reflects tumor aggressiveness. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is the Government's intention to solicit and negotiate with only this source. This notice of intent is not a request for competitive proposals. IAW FAR 5.207 all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. This is not a solicitation or request for offers. No solicitation package is available. Any response to this notice must show clear and convincing evidence that demonstrates the ability to comply with the requirement and that competition would be advantageous to the Government. The Government will not pay for information submitted. A determination not to compete based on responses to this notice is solely within the discretion of the Government. All responses to this intent to sole source must be emailed to Thomas Bellamy: thomas.bellamy@va.gov & Samantha Jarrett: samantha.jarrett@va.gov by 4:00 p.m. EST November 12th, 2026. | - | Special Notice | 11/12/2026 |
Additional Details
Solicitation Number
68HERW27Q0002
Archive Date
Oct 31, 2026
Office Address
Cincinnati, OH, 45268